Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/56355 
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJönsson, Bengten
dc.contributor.authorLundkvist, Jonasen
dc.contributor.authorPersson, Björnen
dc.date.accessioned2012-03-28T13:11:05Z-
dc.date.available2012-03-28T13:11:05Z-
dc.date.issued2002-
dc.identifier.urihttp://hdl.handle.net/10419/56355-
dc.language.isosween
dc.publisher|aStockholm School of Economics, The Economic Research Institute (EFI) |cStockholmen
dc.relation.ispartofseries|aSSE/EFI Working Paper Series in Economics and Finance |x505en
dc.subject.jelI11en
dc.subject.ddc330en
dc.subject.stwPharmazeutisches Produkten
dc.subject.stwSchwedenen
dc.subject.stwPharmazeutische Forschungen
dc.titleNya läkemedel i Sverige: Innovationshöjd, prissättning och marknadsframgång-
dc.typeWorking Paperen
dc.identifier.ppn353676365en
dc.rightshttp://www.econstor.eu/dspace/Nutzungsbedingungenen

Files in This Item:
File
Size
985.53 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.